Our partners

News

diagene and Clinical Data in Cardiac Channelopathy Test Distribution Agreement for Germany, Switzerland and Austria

diagene laboratories inc. has announced that its Routine Laboratory Division has entered into a distribution agreement with Clinical Data, Inc. (NASDAQ: CLDA, Newton, MA 02458, USA), a worldwide leader in providing comprehensive molecular and pharmacogenomics services as well as genetic tests to improve patient care.

diagene has exclusive rights to market and sell Clinical Data's FAMILION® test in Germany, Switzerland, and Austria. FAMILION is a genetic test designed to identify mutations in people with inherited cardiac channelopathies such as Long QT Syndrome (LQTS) and Brugada Syndrome.

Company networks

diagene laboratories inc. is part of a large international network. diagene has e.g. collaborations with SpecialtyLabs (Valencia, CA 91355, USA), Clinical Data (Newton, MA 02458, USA), Novartis (CH-4002 Basel, Switzerland), Roche (CH-4070 Basel, Switzerland), AstraZeneca (London W1K 1LN, United Kingdom).

diagene laboratories inc. is embedded in a network of Institutes and Universities in Switzerland as well in other countries and is member of the business parc (Switzerland), the Innocel Innovation Center (Germany), and the trinational BioValley association.